Description

-Semaglutide is an FDA approved injection for the treatment of obesity. It is administered as a subcutaneous injection and is taken once per week. Semaglutide slows down the rate at which your stomach sends foods to your large intestine, which results in a longer feeling of fullness. Patients on Semaglutide have reported a reduced appetite and reduced cravings for sweets. Patients also report that over eating while on Semaglutide result in unpleasant side effects, such as nausea, which discourages poor eating habits.

Video

2 Reviews

  • admin

    3.8

    At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate

  • Demo

    4.3

    Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,

Add Review & Rate

Add a review

Quality
Location
Service
Price